HCM
TMO icon

Highview Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Highview Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,904
Closed -$1.43M – 131
2026
Q1 		$1.43M Buy
2,904
+155
+6% +$84.1K 0.52% 57
2025
Q4 		$1.59M Buy
2,749
+26
+1% +$14.7K 0.56% 52
2025
Q3 		$1.32M Buy
2,723
+1,767
+185% +$822K 0.49% 58
2025
Q2 		$388K Hold
956
– – 0.15% 87
2025
Q1 		$476K Hold
956
– – 0.2% 76
2024
Q4 		$497K Sell
956
-25
-3% -$13.7K 0.19% 87
2024
Q3 		$607K Buy
981
+25
+3% +$14.8K 0.25% 80
2024
Q2 		$529K Sell
956
-10
-1% -$5.73K 0.22% 85
2024
Q1 		$561K Sell
966
-189
-16% -$106K 0.25% 84
2023
Q4 		$613K Sell
1,155
-2,612
-69% -$1.26M 0.33% 70
2023
Q3 		$1.91M Sell
3,767
-145
-4% -$77.3K 1.09% 24
2023
Q2 		$2.04M Buy
3,912
+34
+0.9% +$18.3K 1.1% 23
2023
Q1 		$2.24M Buy
3,878
+163
+4% +$91.9K 1.29% 16
2022
Q4 		$2.05M Sell
3,715
-274
-7% -$145K 1.25% 17
2022
Q3 		$2.02M Buy
3,989
+299
+8% +$167K 1.5% 17
2022
Q2 		$2M Buy
3,690
+23
+0.6% +$12.7K 1.54% 16
2022
Q1 		$2.17M Buy
3,667
+609
+20% +$350K 1.39% 18
2021
Q4 		$2.04M Buy
+3,058
New +$1.91M 1.32% 16

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Highview Capital Management's TMO Position: Q2 2026 in Review

Highview Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 2,904 shares — an estimated $1.43M sold.

Highview Capital Management first reported a position in TMO in Q4 2021 and held it in 18 quarters. The position peaked at $2.24M in Q1 2023. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Highview Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Highview Capital Management sold 2,904 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.43M.
  • Highview Capital Management first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 18 quarters.
  • Highview Capital Management's Thermo Fisher Scientific position peaked at $2.24M in Q1 2023.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Highview Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.